AVEO stock continued to gain momentum in Tuesday’s session and was recently trading up by 13.50% to $1.26 USD, extending its winning streak for the third straight session. Shares of AVEO Pharmaceuticals (NASDAQ:AVEO), a biopharmaceutical company, are up over 115% since March 26th, 2019 amid several new developments.
Last week, AVEO stock was moving up on rumors that the company may be acquired by AstraZeneca PLC (NYSE:AZN) in the second quarter of 2019.
Moreover, today’s extended rally has been driven by the announcement of positive results from a trial related to acute myeloid leukemia. ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.